Jim Simons Neuro Bo Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.4 - $0.9 $23,742 - $53,420	59,356 New	59,356 $28,000
Q1 2022 May 13, 2022	SELL	$0.72 - $1.54 $16,590 - $35,486	-23,043 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.22 - $2.5 $28,112 - $57,607	23,043 New	23,043 $28,000
Q3 2020 Nov 13, 2020	SELL	$5.41 - $8.67 $64,379 - $103,173	-11,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.05 - $29.44 $95,795 - $350,336	11,900 New	11,900 $96,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.